Our free 60-minute webinar was designed for biotech executives and investors considering a going-public transaction. This free webinar provided a comprehensive overview of the various pathways to going public, with a focus on the unique considerations and challenges faced by companies in the life sciences sector.
Going Public: Strategies for Biotechs
A Live Webinar
August 27, 2025 • 12 pm ET (Free to Attend)
Watch the Webinar
Missed the live session? No problem. We’ve made the full recording available so you can catch up at your convenience. Inside, you’ll get the same insights, discussions, and takeaways that our live audience experienced.
Already Registered? Simply click the link below and enjoy the replay.
Didn’t Register Yet? Click the link below and fill out the quick form to unlock instant access. Registration is free and gives you full viewing rights to this recording (plus updates on future webinars).
What We Discussed
- Why biotech companies go public including access to capital and the importance of public company status for partnering and M&A
- Current market conditions and recent trends for biotech transactions
- Different approaches to going public: IPOs, SPACs, Reverse Mergers, and Reg A
- Regulatory, legal and financial readiness: Preparing your filings, disclosures, and financial/audit prep
- Understanding life as a public company and how biotech differs from other industries with regard to valuations
- Building your public company infrastructure and creating an investor relations playbook
Our Webinar Panelists
Richard Anslow
Partner
Ellenoff Grossman & Schole
Mark Elenowitz
Managing Director
Digital Offering
Mitch Nussbaum
Co-Chairman
Loeb & Loeb
Steven Dresner
Founder
DealFlow Events
This webinar was hosted by DealFlow Events, organizers of The PIPEs Conference, The SPAC Conference, The Venture Debt Conference, and other industry-leading events. Have questions? Email PJ Daniels at pjd@dealflowevents.com or call (516) 876-8011.